5HLS

Crystal structure of the first bromodomain of human BRD4 bound to CPI-0610


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.182 Å
  • R-Value Free: 0.277 
  • R-Value Work: 0.186 

wwPDB Validation 3D Report Full Report


This is version 1.1 of the entry. See complete history

Literature

Identification of a Benzoisoxazoloazepine Inhibitor (CPI-0610) of the Bromodomain and Extra-Terminal (BET) Family as a Candidate for Human Clinical Trials.

Albrecht, B.K.Gehling, V.S.Hewitt, M.C.Vaswani, R.G.Cote, A.Leblanc, Y.Nasveschuk, C.G.Bellon, S.Bergeron, L.Campbell, R.Cantone, N.Cooper, M.R.Cummings, R.T.Jayaram, H.Joshi, S.Mertz, J.A.Neiss, A.Normant, E.O'Meara, M.Pardo, E.Poy, F.Sandy, P.Supko, J.Sims, R.J.Harmange, J.C.Taylor, A.M.Audia, J.E.

(2016) J.Med.Chem. 59: 1330-1339

  • DOI: 10.1021/acs.jmedchem.5b01882
  • Primary Citation of Related Structures:  

  • PubMed Abstract: 
  • In recent years, inhibition of the interaction between the bromodomain and extra-terminal domain (BET) family of chromatin adaptors and acetyl-lysine residues on chromatin has emerged as a promising approach to regulate the expression of important di ...

    In recent years, inhibition of the interaction between the bromodomain and extra-terminal domain (BET) family of chromatin adaptors and acetyl-lysine residues on chromatin has emerged as a promising approach to regulate the expression of important disease-relevant genes, including MYC, BCL-2, and NF-κB. Here we describe the identification and characterization of a potent and selective benzoisoxazoloazepine BET bromodomain inhibitor that attenuates BET-dependent gene expression in vivo, demonstrates antitumor efficacy in an MV-4-11 mouse xenograft model, and is currently undergoing human clinical trials for hematological malignancies (CPI-0610).


    Organizational Affiliation

    Constellation Pharmaceuticals , 215 First Street, Suite 200, Cambridge, Massachusetts 02142, United States.




Macromolecules

Find similar proteins by: Sequence  |  Structure

Entity ID: 1
MoleculeChainsSequence LengthOrganismDetails
Bromodomain-containing protein 4
A
128Homo sapiensMutation(s): 0 
Gene Names: BRD4 (HUNK1)
Find proteins for O60885 (Homo sapiens)
Go to Gene View: BRD4
Go to UniProtKB:  O60885
Small Molecules
Ligands 1 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
62G
Query on 62G

Download SDF File 
Download CCD File 
A
CPI-0610
2-[(4S)-6-(4-chlorophenyl)-1-methyl-4H-[1,2]oxazolo[5,4-d][2]benzazepin-4-yl]acetamide
C20 H16 Cl N3 O2
GCWIQUVXWZWCLE-INIZCTEOSA-N
 Ligand Interaction
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.182 Å
  • R-Value Free: 0.277 
  • R-Value Work: 0.186 
  • Space Group: P 21 21 21
Unit Cell:
Length (Å)Angle (°)
a = 33.788α = 90.00
b = 47.634β = 90.00
c = 77.775γ = 90.00
Software Package:
Software NamePurpose
DENZOdata reduction
SCALEPACKdata scaling
REFMACrefinement
PHASERphasing

Structure Validation

View Full Validation Report or Ramachandran Plots



Entry History 

Deposition Data

Revision History 

  • Version 1.0: 2016-02-10
    Type: Initial release
  • Version 1.1: 2016-03-09
    Type: Database references